Literature DB >> 10664060

Multifocal ERG in chloroquine retinopathy: regional variance of retinal dysfunction.

U Kellner1, H Kraus, M H Foerster.   

Abstract

BACKGROUND: A study was carried out to evaluate the regional variance of retinal dysfunction in chloroquine retinopathy.
METHODS: In three patients with different stages of chloroquine retinopathy, ophthalmologic evaluations including recording of full-field electroretinogram (ISCEV standard) and multifocal electroretinogram were performed.
RESULTS: In one patient with mild chloroquine retinopathy the visual acuity, visual fields and full-field electroretinogram were normal, but retinal dysfunction was indicated by color vision disturbances. The second patient had moderate chloroquine retinopathy with normal visual acuity, visual fields and dark-adapted full-field electroretinogram; light-adapted and flicker full-field electroretinogram responses were, however, borderline and color vision was abnormal. The third patient had severe chloroquine retinopathy with reduced visual acuity, visual field and color vision defects, and a reduced full-field electroretinogram. In the multifocal electroretinogram, recorded with 61 hexagons, amplitudes and implicit times were evaluated in rings surrounding the center. In all three patients severe dysfunction (either amplitudes or implicit times) was found in the parafoveal and perifoveal areas. In the fovea and towards the periphery the function was normal or only moderately reduced.
CONCLUSION: Chloroquine retinopathy of different severity presents with characteristic alterations in the multifocal electroretinogram. Regional distribution of cone dysfunction is in agreement with previously reported histologic findings. The multifocal electroretinogram can detect retinal dysfunction in chloroquine retinopathy even when the full-field electroretinogram is normal and retinal alterations are subtle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10664060     DOI: 10.1007/s004170050016

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  22 in total

1.  Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy.

Authors:  Timothy Y Y Lai; Jasmine W S Ngai; Wai-Man Chan; Dennis S C Lam
Journal:  Doc Ophthalmol       Date:  2006-06-28       Impact factor: 2.379

2.  Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.

Authors:  Susann Missner; Ulrich Kellner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-04       Impact factor: 3.117

3.  Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up.

Authors:  Paul Salu; André Uvijls; Pierre van den Brande; Bart P Leroy
Journal:  Doc Ophthalmol       Date:  2010-04-16       Impact factor: 2.379

4.  [Ophthalmologic screening history and vision-targeted health status of patients suffering from chloroquine maculopathy].

Authors:  R Bergholz; K Rüther; H Tillack; A M Joussen; J Schroeter
Journal:  Ophthalmologe       Date:  2013-07       Impact factor: 1.059

Review 5.  Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.

Authors:  Radouil Tzekov
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

6.  Influence of cataract on the multifocal ERG recording--a pre- and postoperative comparison.

Authors:  Ursula V Wördehoff; Anja M Palmowski; Bernhild Heinemann-Vernaleken; Reiner Allgayer; Klaus W Ruprecht
Journal:  Doc Ophthalmol       Date:  2004-01       Impact factor: 2.379

7.  ERG findings in patients using hydroxychloroquine.

Authors:  Radouil T Tzekov; Alexandra Serrato; Michael F Marmor
Journal:  Doc Ophthalmol       Date:  2004-01       Impact factor: 2.379

8.  Assessing hydroxychloroquine toxicity by the multifocal ERG.

Authors:  Michael N Moschos; Marilita M Moschos; Michael Apostolopoulos; John A Mallias; Christos Bouros; George P Theodossiadis
Journal:  Doc Ophthalmol       Date:  2004-01       Impact factor: 2.379

Review 9.  [Typical questions from the rheumatologist to the ophthalmologist and cooperating radiologist].

Authors:  B Nölle; M Both; M Heller; J B Roider
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

10.  Electrophysiological and structural assessment of the central retina following intravitreal injection of bevacizumab for treatment of macular edema.

Authors:  Rohit Shetty; Sivakami A Pai; Ajoy Vincent; Nitin Shetty; Kannan M Narayana; Babi Sinha; Bhujang K Shetty
Journal:  Doc Ophthalmol       Date:  2007-10-25       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.